These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29330557)

  • 1. Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.
    Allen A; Wang C; Caproni LJ; Sugiyarto G; Harden E; Douglas LR; Duriez PJ; Karbowniczek K; Extance J; Rothwell PJ; Orefo I; Tite JP; Stevenson FK; Ottensmeier CH; Savelyeva N
    Cancer Immunol Immunother; 2018 Apr; 67(4):627-638. PubMed ID: 29330557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection.
    Rottembourg D; Filippi CM; Bresson D; Ehrhardt K; Estes EA; Oldham JE; von Herrath MG
    J Immunol; 2010 Jun; 184(12):7100-7. PubMed ID: 20483769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.
    Scott VL; Patel A; Villarreal DO; Hensley SE; Ragwan E; Yan J; Sardesai NY; Rothwell PJ; Extance JP; Caproni LJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1972-82. PubMed ID: 26091432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
    Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
    Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro assay of immunostimulatory activities of plasmid vectors.
    Jiang W; Reich CF; Pisetsky DS
    Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
    Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-Based Virus-Like Particle Immunogenicity and Its Modulation by Toll-Like Receptor Activation.
    Pitoiset F; Vazquez T; Levacher B; Nehar-Belaid D; Dérian N; Vigneron J; Klatzmann D; Bellier B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
    Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
    Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.
    Spies B; Hochrein H; Vabulas M; Huster K; Busch DH; Schmitz F; Heit A; Wagner H
    J Immunol; 2003 Dec; 171(11):5908-12. PubMed ID: 14634101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
    Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
    Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
    Colluru VT; McNeel DG
    Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies.
    Kim TW; Hung CF; Boyd D; Juang J; He L; Kim JW; Hardwick JM; Wu TC
    J Immunol; 2003 Sep; 171(6):2970-6. PubMed ID: 12960321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.
    Nakagawa T; Tanino T; Onishi M; Tofukuji S; Kanazawa T; Ishioka Y; Itoh T; Kugimiya A; Katayama K; Yamamoto T; Nagira M; Ishii KJ
    Front Immunol; 2021; 12():803090. PubMed ID: 35003132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.
    Sun YY; Peng S; Han L; Qiu J; Song L; Tsai Y; Yang B; Roden RB; Trimble CL; Hung CF; Wu TC
    Clin Cancer Res; 2016 Feb; 22(3):657-69. PubMed ID: 26420854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
    An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
    Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.
    Knudsen ML; Mbewe-Mvula A; Rosario M; Johansson DX; Kakoulidou M; Bridgeman A; Reyes-Sandoval A; Nicosia A; Ljungberg K; Hanke T; Liljeström P
    J Virol; 2012 Apr; 86(8):4082-90. PubMed ID: 22318135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.